{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T06:18:44Z","timestamp":1682057924608},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2023,4,1]]},"DOI":"10.1001\/jamaophthalmol.2023.0018","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T16:32:44Z","timestamp":1677774764000},"page":"407","source":"Crossref","is-referenced-by-count":0,"title":["Is Anti\u2013Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?"],"prefix":"10.1001","volume":"141","author":[{"given":"Vasantha H. S.","family":"Kumar","sequence":"first","affiliation":[{"name":"Center for Developmental Biology of the Lung, Department of Pediatrics, University at Buffalo, Buffalo, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"11","key":"ele230003r1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jamaophthalmol.2022.3788","article-title":"Pulmonary hypertension in preterm infants treated with laser vs anti-vascular endothelial growth factor therapy for retinopathy of prematurity.","volume":"140","author":"Nitkin","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"ele230003r2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/jp.2016.250","article-title":"Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.","volume":"37","author":"Al-Ghanem","year":"2017","journal-title":"J Perinatol"},{"issue":"4","key":"ele230003r3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1165\/rcmb.2014-0045TR","article-title":"The role of vascular endothelial growth factor in pulmonary arterial hypertension. the angiogenesis paradox.","volume":"51","author":"Voelkel","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"ele230003r4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"10208","key":"ele230003r5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2802119\/jamaophthalmology_kumar_2023_le_230003_1680880087.73534.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T15:18:23Z","timestamp":1682003903000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2802119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.0018","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}